• BranchLab closed USD 26 million Series A financing led by McKesson Ventures, funding expansion of its Pathwai AI platform for biopharma commercialization.
• New York-based company uses privacy-safe, aggregated data to generate real-time insights intended to improve pharma audience targeting and patient activation without relying on individual-level information.
• Round brought total funding to USD 35 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Ventures LLC published the original content used to generate this news brief on May 13, 2026, and is solely responsible for the information contained therein.